Baker Bros. Advisors as of March 31, 2015
Portfolio Holdings for Baker Bros. Advisors
Baker Bros. Advisors holds 130 positions in its portfolio as reported in the March 2015 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Pharmacyclics | 19.2 | $2.3B | 9.0M | 255.95 | |
Incyte Corporation (INCY) | 11.3 | $1.4B | 15M | 91.66 | |
Synageva Biopharma | 9.5 | $1.1B | 12M | 97.53 | |
Seattle Genetics | 8.5 | $1.0B | 29M | 35.35 | |
Salix Pharmaceuticals Inc note 2.750% 5/1 | 6.7 | $802M | 216M | 3.71 | |
ACADIA Pharmaceuticals (ACAD) | 5.5 | $668M | 21M | 32.59 | |
BioMarin Pharmaceutical (BMRN) | 4.3 | $524M | 4.2M | 124.62 | |
Incyte Corp Ltd conv | 4.2 | $508M | 275M | 1.85 | |
Incyte Corp Incy Cvt 144a 0.37 convert | 3.9 | $471M | 259M | 1.82 | |
Incyte Corp note 4.750%10/0 | 3.5 | $422M | 40M | 10.43 | |
Genomic Health | 3.5 | $417M | 14M | 30.55 | |
Anacor Pharmaceuticals In | 2.0 | $243M | 4.2M | 57.85 | |
Biomarin Pharmaceutical Inc note 1.875% 4/2 | 1.1 | $137M | 22M | 6.12 | |
Invitae (NVTAQ) | 0.9 | $110M | 6.6M | 16.76 | |
Spark Therapeutics | 0.9 | $103M | 1.3M | 77.50 | |
Dyax | 0.8 | $101M | 6.0M | 16.76 | |
Bellicum Pharma | 0.8 | $97M | 4.2M | 23.17 | |
BioCryst Pharmaceuticals (BCRX) | 0.8 | $95M | 11M | 9.03 | |
Gilead Sciences conv | 0.8 | $90M | 21M | 4.31 | |
Medivation Inc note 2.625% 4/0 | 0.7 | $85M | 34M | 2.51 | |
Mirati Therapeutics | 0.7 | $82M | 2.8M | 29.32 | |
Acorda Therap note 1.75% 6/15 | 0.5 | $61M | 60M | 1.02 | |
Cerus Corporation (CERS) | 0.5 | $57M | 14M | 4.17 | |
XOMA CORP Common equity shares | 0.5 | $54M | 15M | 3.64 | |
Versartis | 0.5 | $55M | 3.0M | 18.37 | |
XenoPort | 0.4 | $46M | 6.5M | 7.12 | |
Array BioPharma | 0.3 | $42M | 5.7M | 7.37 | |
Slxp 1 1/2 03/15/19 | 0.3 | $39M | 15M | 2.66 | |
Heron Therapeutics (HRTX) | 0.3 | $38M | 2.6M | 14.55 | |
Dbv Technologies S A | 0.3 | $36M | 1.5M | 23.36 | |
Halozyme Therapeutics (HALO) | 0.3 | $32M | 2.2M | 14.28 | |
Catalyst Pharmaceutical Partners (CPRX) | 0.3 | $33M | 7.6M | 4.33 | |
Insmed (INSM) | 0.3 | $33M | 1.6M | 20.80 | |
Tg Therapeutics (TGTX) | 0.3 | $32M | 2.1M | 15.48 | |
Derma Sciences | 0.2 | $29M | 3.5M | 8.47 | |
Progenics Pharmaceuticals | 0.2 | $26M | 4.4M | 5.98 | |
Idera Pharmaceuticals | 0.2 | $26M | 7.0M | 3.71 | |
Alder Biopharmaceuticals | 0.2 | $25M | 880k | 28.86 | |
Gilead Sciences (GILD) | 0.2 | $25M | 250k | 98.13 | |
Acorda Therapeutics | 0.2 | $25M | 739k | 33.28 | |
Sangamo Biosciences (SGMO) | 0.2 | $22M | 1.4M | 15.68 | |
Neurocrine Biosciences (NBIX) | 0.2 | $22M | 542k | 39.71 | |
Kythera Biopharmaceuticals I | 0.1 | $18M | 354k | 50.15 | |
Bluebird Bio (BLUE) | 0.1 | $18M | 147k | 120.77 | |
Biomarin Pharmaceutical Inc note 0.750%10/1 | 0.1 | $18M | 12M | 1.47 | |
Vanda Pharmaceuticals (VNDA) | 0.1 | $16M | 1.8M | 9.30 | |
Repros Therapeutics | 0.1 | $17M | 2.0M | 8.59 | |
Foamix Pharmaceuticals | 0.1 | $17M | 1.8M | 9.25 | |
Novavax | 0.1 | $16M | 1.9M | 8.27 | |
Clovis Oncology | 0.1 | $15M | 203k | 74.23 | |
Lion Biotechnologies | 0.1 | $16M | 1.3M | 12.11 | |
Omeros Corporation (OMER) | 0.1 | $14M | 637k | 22.03 | |
Agios Pharmaceuticals (AGIO) | 0.1 | $14M | 150k | 94.30 | |
Xencor (XNCR) | 0.1 | $13M | 872k | 15.32 | |
Threshold Pharmaceuticals | 0.1 | $12M | 2.9M | 4.06 | |
Alcobra | 0.1 | $10M | 1.8M | 5.63 | |
Macrogenics (MGNX) | 0.1 | $9.6M | 305k | 31.37 | |
Aerie Pharmaceuticals | 0.1 | $9.4M | 299k | 31.34 | |
Ultragenyx Pharmaceutical (RARE) | 0.1 | $9.2M | 149k | 62.09 | |
Aquinox Pharmaceuticals | 0.1 | $9.8M | 1.2M | 8.22 | |
Osiris Therapeutics | 0.1 | $8.8M | 499k | 17.58 | |
ImmunoGen | 0.1 | $8.9M | 1000k | 8.95 | |
Sunesis Pharmaceuticals | 0.1 | $7.8M | 3.2M | 2.45 | |
Arrowhead Research | 0.1 | $8.7M | 1.3M | 6.76 | |
Proqr Thrapeutics N V shs euro (PRQR) | 0.1 | $8.8M | 400k | 21.88 | |
Karyopharm Therapeutics (KPTI) | 0.1 | $6.6M | 217k | 30.61 | |
La Jolla Pharmaceuticl Com Par | 0.1 | $7.5M | 412k | 18.30 | |
Celladon | 0.1 | $6.9M | 367k | 18.94 | |
Concert Pharmaceuticals I equity | 0.1 | $7.5M | 496k | 15.15 | |
Ligand Pharmaceuticals In (LGND) | 0.1 | $5.7M | 73k | 77.11 | |
Foundation Medicine | 0.1 | $6.0M | 124k | 48.11 | |
Ignyta | 0.1 | $5.7M | 571k | 9.95 | |
Juno Therapeutics | 0.1 | $6.1M | 100k | 60.66 | |
Infinity Pharmaceuticals (INFIQ) | 0.0 | $4.3M | 305k | 13.98 | |
Amarin Corporation (AMRN) | 0.0 | $5.2M | 2.2M | 2.34 | |
Transition Therapeutics | 0.0 | $5.3M | 769k | 6.83 | |
Discovery Laboratories | 0.0 | $4.2M | 3.6M | 1.19 | |
Cytrx | 0.0 | $4.4M | 1.3M | 3.37 | |
D Stemline Therapeutics | 0.0 | $4.8M | 334k | 14.47 | |
Epizyme | 0.0 | $4.4M | 233k | 18.78 | |
Chimerix (CMRX) | 0.0 | $4.3M | 115k | 37.69 | |
ISIS Pharmaceuticals | 0.0 | $3.6M | 57k | 63.67 | |
Zogenix | 0.0 | $3.1M | 2.3M | 1.37 | |
Tekmira Pharmaceuticals Corporation | 0.0 | $3.2M | 181k | 17.46 | |
Array Biopharma Inc note 3.000% 6/0 | 0.0 | $3.8M | 3.0M | 1.25 | |
Receptos | 0.0 | $3.9M | 24k | 164.90 | |
Zafgen | 0.0 | $3.8M | 95k | 39.61 | |
Lipocine | 0.0 | $3.4M | 489k | 6.90 | |
Sage Therapeutics (SAGE) | 0.0 | $3.8M | 75k | 50.23 | |
Aurinia Pharmaceuticals (AUPH) | 0.0 | $3.1M | 712k | 4.38 | |
Assembly Biosciences | 0.0 | $3.3M | 250k | 13.24 | |
Neuroderm Ltd F | 0.0 | $3.4M | 250k | 13.42 | |
Bellerophon Therapeutics | 0.0 | $3.2M | 350k | 9.18 | |
BioDelivery Sciences International | 0.0 | $2.7M | 256k | 10.50 | |
Ironwood Pharmaceuticals (IRWD) | 0.0 | $2.7M | 169k | 16.00 | |
Achillion Pharmaceuticals | 0.0 | $2.1M | 214k | 9.86 | |
ZIOPHARM Oncology | 0.0 | $2.0M | 189k | 10.77 | |
Palatin Technologies | 0.0 | $2.1M | 2.1M | 1.02 | |
Biota Pharmaceuticals | 0.0 | $2.0M | 863k | 2.30 | |
Enanta Pharmaceuticals (ENTA) | 0.0 | $2.3M | 75k | 30.61 | |
Mast Therapeutics | 0.0 | $2.3M | 4.7M | 0.48 | |
Auspex Pharmaceuticals | 0.0 | $2.5M | 25k | 100.28 | |
Intra Cellular Therapies (ITCI) | 0.0 | $2.5M | 104k | 23.88 | |
Vitae Pharmaceuticals | 0.0 | $2.2M | 188k | 11.71 | |
Affimed Therapeutics B V | 0.0 | $2.5M | 400k | 6.30 | |
Protalix Biotherapeutics Inc note 4.500% 9/1 | 0.0 | $2.6M | 3.5M | 0.75 | |
Proteon Therapeutics | 0.0 | $2.0M | 173k | 11.63 | |
Synta Pharmaceuticals | 0.0 | $949k | 489k | 1.94 | |
Rigel Pharmaceuticals | 0.0 | $1.3M | 357k | 3.57 | |
OraSure Technologies (OSUR) | 0.0 | $1.5M | 229k | 6.54 | |
Alnylam Pharmaceuticals (ALNY) | 0.0 | $1.2M | 11k | 104.41 | |
Ohr Pharmaceutical | 0.0 | $941k | 370k | 2.54 | |
Acceleron Pharma | 0.0 | $1.1M | 29k | 38.07 | |
Ophthotech | 0.0 | $1.7M | 36k | 46.54 | |
Achaogen | 0.0 | $976k | 100k | 9.76 | |
Uniqure Nv (QURE) | 0.0 | $730k | 30k | 24.33 | |
Mediwound Ltd cmn | 0.0 | $1.6M | 225k | 7.24 | |
Aldeyra Therapeutics (ALDX) | 0.0 | $1.4M | 142k | 10.18 | |
Loxo Oncology | 0.0 | $1.2M | 100k | 12.45 | |
Marinus Pharmaceuticals | 0.0 | $1.8M | 200k | 8.99 | |
Dermira | 0.0 | $1.5M | 100k | 15.35 | |
Cellectis S A (CLLS) | 0.0 | $1.7M | 50k | 34.58 | |
Ascendis Pharma A S (ASND) | 0.0 | $1.7M | 100k | 17.35 | |
Aegerion Pharmaceuticals | 0.0 | $374k | 14k | 26.15 | |
Cyclacel Pharmaceuticals Inc pfd conv ex 6% (CYCCP) | 0.0 | $86k | 13k | 6.49 | |
Chemocentryx | 0.0 | $370k | 49k | 7.54 | |
Biodel | 0.0 | $36k | 30k | 1.19 | |
Five Prime Therapeutics | 0.0 | $440k | 19k | 22.86 | |
Biotime Inc wts oct 1 18 | 0.0 | $40k | 20k | 1.99 | |
Aptose Biosciences | 0.0 | $181k | 33k | 5.42 |